Buscar
Sanofi SA
SNYAñadir a la lista de seguimiento
43.160USD
+1.530+3.68%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
103.60BCap. mercado
12.00P/E TTM
Más Datos de Sanofi SA Compañía
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Información de Sanofi SA
Símbolo de cotizaciónSNY
Nombre de la empresaSanofi SA
Fecha de salida a bolsaJul 01, 2002
Director ejecutivoHudson (Paul)
Número de empleados84587
Tipo de seguridadDepository Receipt
Fin del año fiscalJul 01
Dirección46 Avenue de la Grande Armee
CiudadPARIS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísFrance
Código postal75017
Teléfono33153774000
Sitio Webhttps://www.sanofi.com/
Símbolo de cotizaciónSNY
Fecha de salida a bolsaJul 01, 2002
Director ejecutivoHudson (Paul)
Ejecutivos de Sanofi SA
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Mr. Thomas Triomphe
Mr. Thomas Triomphe
Executive Vice President - Vaccines, Member of the Executive Committee
Executive Vice President - Vaccines, Member of the Executive Committee
--
--
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Mr. Wolfgang Laux
Mr. Wolfgang Laux
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Tran Yann
Mr. Tran Yann
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Roy Papatheodorou
Mr. Roy Papatheodorou
Executive Vice President, General Counsel, Member of the Executive Committee
Executive Vice President, General Counsel, Member of the Executive Committee
--
--
Mr. Brendan O' Callaghan
Mr. Brendan O' Callaghan
Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee
Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee
--
--
Ms. Carole Ferrand
Ms. Carole Ferrand
Independent Director
Independent Director
--
--
Mr. Emile Voest, M.D., Ph.D.
Mr. Emile Voest, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Antoine Yver, M.D.
Dr. Antoine Yver, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Mr. Thomas Triomphe
Mr. Thomas Triomphe
Executive Vice President - Vaccines, Member of the Executive Committee
Executive Vice President - Vaccines, Member of the Executive Committee
--
--
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Mr. Wolfgang Laux
Mr. Wolfgang Laux
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Tran Yann
Mr. Tran Yann
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Roy Papatheodorou
Mr. Roy Papatheodorou
Executive Vice President, General Counsel, Member of the Executive Committee
Executive Vice President, General Counsel, Member of the Executive Committee
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Sanofi SA?
Los cinco principales accionistas de Sanofi SA son: Ms. Julie Van Ongevalle
¿Cuántas instituciones poseen acciones de Sanofi SA (SNY)?
A fecha de 2026Q1, 1330 instituciones poseen acciones de Sanofi SA, con un valor de mercado combinado de aproximadamente 225.52M, lo que representa el 9.34% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -36323619.00.